Qiu Du

机构：Taiyuan Central Hospital, Yangzhou University · ORCID：0000-0002-4882-221X

发表论文 55 篇 · 总被引 1356 次 · h-index 22

代表论文

Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 77)
Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway (2021 · Chemico-Biological Interactions · 被引 68)
Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy (2020 · Life Sciences · 被引 66)
Matrine Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review (2022 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 62)
Radix Rehmanniae and Corni Fructus against Diabetic Nephropathy via AGE-RAGE Signaling Pathway (2020 · Journal of Diabetes Research · 被引 42)
Catalpol ameliorates diabetes-induced testicular injury and modulates gut microbiota (2020 · Life Sciences · 被引 36)